|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn233974114 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
080715s2008 sz a ob 001 0 eng d |
010 |
|
|
|a 2007934182
|
040 |
|
|
|a GW5XE
|b eng
|e pn
|c GW5XE
|d OCLCQ
|d N$T
|d YNG
|d UAB
|d E7B
|d UBC
|d MNU
|d IDEBK
|d MHW
|d EBLCP
|d OCLCQ
|d A7U
|d OCLCQ
|d OCLCF
|d BEDGE
|d OCLCQ
|d SLY
|d NLGGC
|d COO
|d YDXCP
|d DEBSZ
|d NUI
|d OCLCQ
|d AZK
|d LOA
|d OCLCO
|d OCLCA
|d COCUF
|d JG0
|d OCLCO
|d MERER
|d OCLCO
|d VT2
|d Z5A
|d MOR
|d OCLCO
|d PIFAG
|d ZCU
|d OTZ
|d OCLCQ
|d MERUC
|d ESU
|d OCLCQ
|d STF
|d OCLCO
|d U3W
|d WRM
|d OCLCQ
|d ICG
|d CEF
|d CRU
|d INT
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d YOU
|d CANPU
|d OCLCQ
|d W2U
|d DKC
|d OCLCO
|d OCLCQ
|d CNTRU
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d AUD
|d ERF
|d OCLCA
|d UKCRE
|d INARC
|d DCT
|d EQF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d OCLCQ
|
015 |
|
|
|a GBA775770
|2 bnb
|
016 |
7 |
|
|a 013951029
|2 Uk
|
019 |
|
|
|a 261068140
|a 316691809
|a 370727597
|a 607353127
|a 613472483
|a 648365074
|a 739155132
|a 880315494
|a 961592514
|a 962656978
|a 966243389
|a 985031974
|a 987732032
|a 988503180
|a 991980503
|a 994845253
|a 1005748437
|a 1007580047
|a 1035709933
|a 1037736167
|a 1038617544
|a 1044265602
|a 1055340548
|a 1056395915
|a 1058699579
|a 1066586080
|a 1077827548
|a 1081282899
|a 1086856571
|a 1153534543
|a 1162693683
|a 1176180379
|a 1204013438
|a 1225345659
|a 1228583427
|
020 |
|
|
|a 9783764382964
|
020 |
|
|
|a 3764382961
|
020 |
|
|
|a 9783764382957
|q (hbk.)
|
020 |
|
|
|a 3764382953
|q (hbk.)
|
020 |
|
|
|a 9786611140915
|
020 |
|
|
|a 6611140913
|
024 |
7 |
|
|a 10.1007/978-3-7643-8296-4.
|2 doi
|
029 |
1 |
|
|a AU@
|b 000043372584
|
029 |
1 |
|
|a AU@
|b 000043375220
|
029 |
1 |
|
|a AU@
|b 000057679157
|
029 |
1 |
|
|a AU@
|b 000060546134
|
029 |
1 |
|
|a DEBBG
|b BV044129141
|
029 |
1 |
|
|a DEBSZ
|b 430480245
|
029 |
1 |
|
|a HEBIS
|b 198462824
|
029 |
1 |
|
|a NZ1
|b 12437193
|
035 |
|
|
|a (OCoLC)233974114
|z (OCoLC)261068140
|z (OCoLC)316691809
|z (OCoLC)370727597
|z (OCoLC)607353127
|z (OCoLC)613472483
|z (OCoLC)648365074
|z (OCoLC)739155132
|z (OCoLC)880315494
|z (OCoLC)961592514
|z (OCoLC)962656978
|z (OCoLC)966243389
|z (OCoLC)985031974
|z (OCoLC)987732032
|z (OCoLC)988503180
|z (OCoLC)991980503
|z (OCoLC)994845253
|z (OCoLC)1005748437
|z (OCoLC)1007580047
|z (OCoLC)1035709933
|z (OCoLC)1037736167
|z (OCoLC)1038617544
|z (OCoLC)1044265602
|z (OCoLC)1055340548
|z (OCoLC)1056395915
|z (OCoLC)1058699579
|z (OCoLC)1066586080
|z (OCoLC)1077827548
|z (OCoLC)1081282899
|z (OCoLC)1086856571
|z (OCoLC)1153534543
|z (OCoLC)1162693683
|z (OCoLC)1176180379
|z (OCoLC)1204013438
|z (OCoLC)1225345659
|z (OCoLC)1228583427
|
037 |
|
|
|a 978-3-7643-8295-7
|b Springer
|n http://www.springerlink.com
|
050 |
|
4 |
|a QP364
|b .I56 2008eb
|
060 |
|
4 |
|a WH 200
|b I32 2008
|
072 |
|
7 |
|a MED
|x 044000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.079
|2 22
|
084 |
|
|
|a R338
|2 clc
|
084 |
|
|
|a R37
|2 clc
|
049 |
|
|
|a UAMI
|
245 |
0 |
4 |
|a The immune synapse as a novel target for therapy /
|c Luis Graca, editor.
|
260 |
|
|
|a Basel ;
|a Boston :
|b Birkhäuser ;
|a [London] :
|b [Springer, distributor],
|c ©2008.
|
300 |
|
|
|a 1 online resource (xi, 192 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
490 |
1 |
|
|a Progress in inflammation research
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a The immune synapse can be compared to a molecular machine that controls T cell activation when getting in contact with an antigen-presenting cell (APC). The immune synapse is involved in the transfer of information across the T cell-APC junction. It plays an essential role in the control and nature of the immune response. In recent years several approaches have been developed to reprogramming the immune response by targeting molecules involved in the immune synapse. Monoclonal antibodies, such as the ones targeting the lymphocyte co-receptor, co-stimulatory and adhesion molecules (CD3, CD4, CD.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a The immune synapse and T cell activation: regulation by chemokines -- The induction of regulatory T cells by targeting the immune synapse -- Infiltrating the immunological synapse: prospects for the use of altered peptide ligands for the treatment of immune pathology -- Targeting CD4 for the induction of dominant tolerance -- Anti-CD3: from T cell depletion to tolerance induction -- Immune modulation by CD40L blockade -- CTLA-4-immunoglobulin and indoleamine 2,3-dioxygenase in dominant tolerance -- Adhesion molecules as therapeutic targets -- E3 ubiquitin ligases and immune tolerance: Targeting the immune synapse from within? -- FOXP3 biochemistry will lead to novel drug approaches for vaccines and diseases that lack suppressor T cells -- Transforming growth factor-?: From its effect in T cell activation to a role in dominant tolerance -- From mice to men: the challenges of developing tolerance-inducing biological drugs for the clinic.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Synapses.
|
650 |
|
0 |
|a Immune response
|x Molecular aspects.
|
650 |
|
0 |
|a Immune response
|x Regulation.
|
650 |
|
2 |
|a Antigen Presentation
|x physiology
|
650 |
|
2 |
|a Immunological Synapses
|x physiology
|
650 |
|
2 |
|a T-Lymphocytes
|x physiology
|
650 |
|
2 |
|a Synapses
|
650 |
|
6 |
|a Synapses.
|
650 |
|
6 |
|a Réaction immunitaire
|x Aspect moléculaire.
|
650 |
|
6 |
|a Réaction immunitaire
|x Régulation.
|
650 |
|
7 |
|a MEDICAL
|x Immunology.
|2 bisacsh
|
650 |
0 |
7 |
|a Immune response
|x Regulation.
|2 cct
|
650 |
0 |
7 |
|a T-Lymphocytes
|x physiology.
|2 cct
|
650 |
0 |
7 |
|a Lymphocyte Activation.
|2 cct
|
650 |
0 |
7 |
|a Antigens, CD
|x physiology.
|2 cct
|
650 |
0 |
7 |
|a Antigen Presentation.
|2 cct
|
650 |
0 |
7 |
|a Immune Tolerance.
|2 cct
|
650 |
0 |
7 |
|a Synapses.
|2 cct
|
650 |
0 |
7 |
|a Immune response
|x Molecular aspects.
|2 cct
|
650 |
|
7 |
|a Biomédecine.
|2 eclas
|
650 |
|
7 |
|a Sciences de la vie.
|2 eclas
|
650 |
|
7 |
|a Immune response
|x Molecular aspects
|2 fast
|
650 |
|
7 |
|a Immune response
|x Regulation
|2 fast
|
650 |
|
7 |
|a Synapses
|2 fast
|
700 |
1 |
|
|a Graca, Luis,
|c MD.
|1 https://id.oclc.org/worldcat/entity/E39PCjJQ7J3Q6dqh6FVQWtW9H3
|
758 |
|
|
|i has work:
|a The immune synapse as a novel target for therapy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFRKjRfmW8phPgrTKX7d33
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Print version:
|t Immune synapse as a novel target for therapy.
|d Basel ; Boston : Birkhäuser ; [London : Springer, distributor], ©2008
|z 9783764382957
|z 3764382953
|w (DLC) 2007934182
|w (OCoLC)181421041
|
830 |
|
0 |
|a PIR (Series)
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=338156
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26420140
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL338156
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10221629
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 256476
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 114091
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2810005
|
938 |
|
|
|a Internet Archive
|b INAR
|n immunesynapseasn0000unse
|
994 |
|
|
|a 92
|b IZTAP
|